Clinical trials
Leukemia trials in the United States with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 5 |
| M.D. Anderson Cancer Center | 5 |
| Alliance for Clinical Trials in Oncology | 4 |
| Cambridge Antibody Technology | 3 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| University of British Columbia | 2 |
| ALZA | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Antisoma Research | 1 |
| Blue Note Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 49 |
| Lymphoma | 18 |
| Leukemia, Myeloid, Acute | 17 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 14 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 |
| Myelodysplastic Syndromes | 12 |
| Burkitt Lymphoma | 10 |
| Lymphoma, Large B-Cell, Diffuse | 10 |
| Lymphoma, Non-Hodgkin | 10 |
| Recurrence | 10 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.